Back to Dashboard
66

ENSG

🏥 Healthcare

The Ensign Group, Inc.

Conservative #177Aggressive #62Low RiskModerate 60ML↑ 20pt
$213.84+0.68%
Day High$214.34
Day Low$207.01
Volume0.3M
Mkt Cap$12.4B
52W Low $11952W High $217
Market Cap
$12.4B
P/E Ratio
36.6
Sector avg: 252.3
Rev Growth
18.7%
Sector avg: 161.5%
Earnings Growth
15.4%
Profit Margin
6.8%
Sector avg: -3292.7%
Debt/Equity
0.99

Why This Score

ENSG scores 65.6 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.

Strengths
  • Strong profitability: ROE of 15.4% exceeds the 15% quality threshold.
Risk Factors
  • Signal divergence: Fundamental and ML signals disagree by a significant margin, reducing confidence.

Minor adjustments (-1.3 points) applied. ENSG's rank of #177 primarily reflects its factor profile relative to the conservative weight vector.

Score Breakdown

Overall Score65.6
Fundamental Score58.1
ML Score82.0

Score by Horizon

3 Month
78.1
6 Month
87.3
Primary
1 Year
91.9

Quality Assessment

A
Earnings Grade
Strong fundamentals, high earnings quality

Position Sizing

Suggested Allocation
5%
Confidence
high

Score Composition Waterfall

How each component affects the final score
Backtested Scoring Levers (IC-calibrated from 30y ElasticNet)
Weinstein (12.1%)
100
Advancing
Sentiment (2.5%)
64
Positive
Analyst (6.4%)
64
Favorable
Tradability (post-hoc)
84
Grade A
Base
62.9
SHAP
+3.0
Factors
+1.0
Divergence
-1.3
Final
65.6
Positive adjustment
Negative adjustment
Base blend
Final score

Factor Breakdown

57AVG
Value55
Quality55
Growth75
Stability60
Investment40

Signal SegmentsComputed from ML features

Fundamental (Valuation, Quality, Growth)54.0
Technical (Momentum, Weinstein, Volatility)89.0
External (Sentiment, Analyst, Macro)82.0
Scores below 50 indicate weakness in that segment relative to the universe.

Data Quality

Score
Features
Confidence
Feature Coverage96%

Growth Estimates

Short-term
+4.8% to +9.9%
Medium-term
+8.1% to +15.9%
Long-term
+12.0% to +22.6%

ML Model Core Features100 trained inputs → ML Score: 82

These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.

Analyst Intelligence
Consensus Score63.5/100
Target Upside+3.5%
Coverage13 analysts
Market Sentiment
Sentiment Score64.2/100
News Volume1 articles
Technical Stage
Weinstein Stage2 — Advancing
12M Momentum+0.7%
6M Momentum+0.2%
Volatility+0.1%
Momentum & Technical
Momentum Acceleration+41.2%
Momentum ConsistencyModerate (0.37)
Relative Strength vs Sector+41.0%
Trend Strength (ADX Proxy)Strong (5.0)
Momentum Quality+0.606
Momentum BreadthBroad ✓
Macro Regime
Bull RegimeYes
High Vol RegimeNo
S&P 500 Return+25.0%
Yield Curve-0.1bp

Sector-Relative AnalysisIn-model features

Value Trap Signal
4%
Low risk
Sector RevGr Rank
P66
Revenue growth vs Healthcare peers
Sector PE Rank
P14
Valuation vs Healthcare peers
Sector FCF Rank
P83
Free cash flow vs Healthcare peers
Growth Deviation
+0.0σ
Z-score vs sector median
Stagnation Flag
NO
Not flagged

Analysis Signals

Scoring Factors
Fundamental score of 60 relative to sector peers60/100
Machine learning model ranks this stock at the 80th percentileP80
ML model weight reduced to 9% due to macro conditions: market in extended rally phase; yield curve inverted (recession indicator); late-cycle economic indicators detected9% ML weight
SHAP feature alignment: +4.4pt (features align with model priorities)
Blend: 91% fund (60.2) + 9% ML (80.0) + SHAP(+4.4) = 66.4
Factor quality: +1.5pt (multi-factor composite)
Risk assessment: low. Annualized volatility 8.4%Low
Market cap adjustment: +2.0 points ($12.4B market cap)+2.0 pts
Divergence penalty: -1.4pt (ML 20pt higher)
Risk Factors

No risk factors identified.

Sector Peer Comparison(Healthcare — Rank #21 of 344 stocks)

StockScoreP/ERev GrowthMarginMkt Cap
ENSG65.636.618.7%6.8%$12.4B
INCY89.615.821.2%25.0%$20.1B
GMAB85.513.122.8%36.4%$18.5B
CPRX82.213.723.5%37.6%$3.0B
VRTX78.032.18.9%32.9%$126.0B
ASND75.716.698.0%-31.7%$13.3B
NBIX74.726.521.4%16.7%$12.5B
ALKS74.616.5-6.4%23.9%$5.5B
AMGN73.826.010.0%21.0%$199.0B
ARGX73.635.178.6%38.0%$50.9B
HOLX73.331.11.7%13.8%$16.8B
REGN72.719.41.0%31.4%$84.9B
ISRG72.361.720.5%28.4%$172.5B
EXEL71.915.17.0%33.7%$11.7B
KRYS71.041.4473.0%30.7%$8.0B
HALO70.216.822.4%43.7%$9.3B
Sector Average37.1252.3161.5%-3292.7%

Company Overviewvia FMP

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

CEO
Barry R. Port
Employees
39,300
Beta
0.87
Industry
Medical - Care Facilities
FMP-Identified Peers

Technical Picturecomputed from daily prices

RSI (14)
82.0
Overbought
Trend
Bullish
10-day vs 50-day MA
From 52W High
-1.4%
High: $216.92
From 52W Low
+80.1%
Low: $118.73
Moving Averages
10-Day
$211.80
Above
20-Day
$197.40
Above
50-Day
$185.20
Above
200-Day
$169.40
Above
60-Day Support
$167.43
60-Day Resistance
$216.92
Weinstein Stage Analysisbased on 200-day SMA framework
Stage 2 — AdvancingScore: 88/100

Stock is in an uptrend above the 200-day moving average. This is the stage where institutional accumulation typically occurs. The 50-day SMA provides support.

Favorable technical position; 50-day SMA acts as support
Price vs 200 SMA
+26.2%
200 SMA Slope (60d)
+10.81%
Rising
Volume Ratio
1.13x
10d avg vs 50d avg
Days in Stage
100
Confidence: 90%

Financial Statementslast 4 quarters via FMP

MetricQ4 2025Q3 2025Q2 2025Q1 2025
Revenue$1.4B$1.3B$1.2B$1.2B
Gross Profit$118M$190M$199M$188M
Operating Income$124M$96M$104M$101M
Net Income$95M$84M$84M$80M
EPS (Diluted)$1.61$1.42$1.44$1.37
Gross Margin8.7%14.7%16.2%16.0%
Operating Margin9.1%7.4%8.5%8.6%
Net Margin7.0%6.5%6.9%6.8%

Why This Stock

HealthcareRevenue growth 18.7%Earnings quality grade A

Tradability FilterGrade A — 84/100Score impact: -9.5pt

Volume
68
384K avg/day
Dollar Vol
100
$82M/day
Float
82
56M shares
Mkt Cap
81
$12.4B
Range
100
83% spread
Composite Liquidity Score84/100
FDCBA

Multi-Year Range Analysis

Sideways: 6/100
YearLowHighRangeStatus
2021$68.29$98.6636.4%Wide
2022$70.29$97.4232.4%Moderate
2023$85.50$115.1129.5%Moderate
2024$110.71$158.4535.5%Wide
2025$118.73$194.0048.1%Wide
3-Year Range
77.6%
Narrow Years
1 / 5
Sideways Penalty
None
Free Float
95.8%
Outstanding Shares
58M
Bid-Ask Spread
83.0%
Institutional Tradable
Yes

Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.